8830 related articles for article (PubMed ID: 9292303)
21. Functional and phenotypic analysis of thymic CD34+CD1a- progenitor-derived dendritic cells: predominance of CD1a+ differentiation pathway.
Dalloul AH; Patry C; Salamero J; Canque B; Grassi F; Schmitt C
J Immunol; 1999 May; 162(10):5821-8. PubMed ID: 10229816
[TBL] [Abstract][Full Text] [Related]
22. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes.
Théry C; Duban L; Segura E; Véron P; Lantz O; Amigorena S
Nat Immunol; 2002 Dec; 3(12):1156-62. PubMed ID: 12426563
[TBL] [Abstract][Full Text] [Related]
23. Intrathymic non-lymphatic hematopoiesis during mammalian ontogenesis.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1998; 12(6):599-618. PubMed ID: 9891223
[TBL] [Abstract][Full Text] [Related]
24. Accessory function of human thymic dendritic cells in Con A-induced proliferation of autologous thymocyte subsets.
Landry D; Doyon L; Poudrier J; Lafontaine M; Pelletier M; Montplaisir S
J Immunol; 1990 Feb; 144(3):836-43. PubMed ID: 1688590
[TBL] [Abstract][Full Text] [Related]
25. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
Foley R; Tozer R; Wan Y
Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
[TBL] [Abstract][Full Text] [Related]
26. Fetal skin-derived MHC class I+, MHC class II- dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells.
Elbe A; Schleischitz S; Strunk D; Stingl G
J Immunol; 1994 Oct; 153(7):2878-89. PubMed ID: 7522244
[TBL] [Abstract][Full Text] [Related]
27. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells.
Scheinecker C; Machold KP; Majdic O; Höcker P; Knapp W; Smolen JS
J Immunol; 1998 Oct; 161(8):3966-73. PubMed ID: 9780165
[TBL] [Abstract][Full Text] [Related]
28. Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors.
Mortarini R; Anichini A; Di Nicola M; Siena S; Bregni M; Belli F; Molla A; Gianni AM; Parmiani G
Cancer Res; 1997 Dec; 57(24):5534-41. PubMed ID: 9407964
[TBL] [Abstract][Full Text] [Related]
29. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
30. Notch signaling regulates the development of a novel type of Thy1-expressing dendritic cell in the thymus.
Ishifune C; Maekawa Y; Nishida J; Kitamura A; Tanigaki K; Yagita H; Yasutomo K
Eur J Immunol; 2011 May; 41(5):1309-20. PubMed ID: 21469122
[TBL] [Abstract][Full Text] [Related]
31. Generation of functionally mature dendritic cells from the multipotential stem cell line FDCP-mix.
Schroeder T; Lange C; Strehl J; Just U
Br J Haematol; 2000 Dec; 111(3):890-7. PubMed ID: 11122152
[TBL] [Abstract][Full Text] [Related]
32. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
33. Developmental regulation of MHC class II transport in mouse dendritic cells.
Pierre P; Turley SJ; Gatti E; Hull M; Meltzer J; Mirza A; Inaba K; Steinman RM; Mellman I
Nature; 1997 Aug; 388(6644):787-92. PubMed ID: 9285592
[TBL] [Abstract][Full Text] [Related]
34. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.
Zhu M; Terasawa H; Gulley J; Panicali D; Arlen P; Schlom J; Tsang KY
Cancer Res; 2001 May; 61(9):3725-34. PubMed ID: 11325845
[TBL] [Abstract][Full Text] [Related]
35. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
36. Thymic T-cell tolerance of neuroendocrine functions: physiology and pathophysiology.
Geenen V; Kecha O; Brilot F; Hansenne I; Renard C; Martens H
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):179-88. PubMed ID: 11292253
[TBL] [Abstract][Full Text] [Related]
37. Identification of mature and immature human thymic dendritic cells that differentially express HLA-DR and interleukin-3 receptor in vivo.
Schmitt C; Fohrer H; Beaudet S; Palmer P; Alpha MJ; Canque B; Gluckman JC; Dalloul AH
J Leukoc Biol; 2000 Dec; 68(6):836-44. PubMed ID: 11129651
[TBL] [Abstract][Full Text] [Related]
38. Targeting dendritic cells for priming cellular immune responses.
Gogolák P; Réthi B; Hajas G; Rajnavölgyi E
J Mol Recognit; 2003; 16(5):299-317. PubMed ID: 14523943
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
40. Normal B cells fail to secrete interleukin-12.
Guéry JC; Ria F; Galbiati F; Adorini L
Eur J Immunol; 1997 Jul; 27(7):1632-9. PubMed ID: 9247571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
